Literature DB >> 21884565

Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children.

L G Mitchell1, N A Goldenberg, C Male, G Kenet, P Monagle, U Nowak-Göttl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21884565     DOI： 10.1111/j.1538-7836.2011.04433.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  38 in total

1.  In Children with Provoked Venous Thromboembolism, Increasing Plasma Coagulability during the First 3 Months Postdiagnosis is Prognostic of Recurrence.

Authors:  Marisol Betensky; M Gail Mueller; Ernest K Amankwah; Neil A Goldenberg
Journal:  Thromb Haemost       Date:  2020-05-05       Impact factor: 5.249

Review 2.  Current and future management of pediatric venous thromboembolism.

Authors:  Bryce A Kerlin
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

3.  Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience.

Authors:  A Moruf; A C Spyropoulos; T Q Schardt; E Gibson; M J Manco-Johnson; M Wang; N A Goldenberg
Journal:  Thromb Res       Date:  2012-06-29       Impact factor: 3.944

4.  The phase 3 pediatric anticoagulant era.

Authors:  Neil A Goldenberg; Brian R Branchford
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

5.  Endovascular thrombolysis to salvage central venous access in children with catheter-associated upper extremity deep vein thrombosis: technique and initial results.

Authors:  Matthew P Lungren; Thomas J Ward; Manish N Patel; John M Racadio; Kamlesh Kukreja
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

6.  Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT Biobank.

Authors:  Marisol Betensky; Ernest K Amankwah; Stephanie Brandal; Allen D Everett; Neil A Goldenberg
Journal:  Blood Adv       Date:  2021-01-12

Review 7.  Association of thrombophilia and catheter-associated thrombosis in children: a systematic review and meta-analysis.

Authors:  S Neshat-Vahid; R Pierce; D Hersey; L J Raffini; E V S Faustino
Journal:  J Thromb Haemost       Date:  2016-07-29       Impact factor: 5.824

8.  Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.

Authors:  Leonardo R Brandão; Manuela Albisetti; Jacqueline Halton; Lisa Bomgaars; Elizabeth Chalmers; Lesley G Mitchell; Ildar Nurmeev; Pavel Svirin; Tomas Kuhn; Ondrej Zapletal; Igor Tartakovsky; Monika Simetzberger; Fenglei Huang; Zhichao Sun; Jörg Kreuzer; Savion Gropper; Martina Brueckmann; Matteo Luciani
Journal:  Blood       Date:  2020-02-13       Impact factor: 22.113

9.  Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation.

Authors:  Riten Kumar; Katherine Harsh; Surbhi Saini; Sarah H O'Brien; Joseph Stanek; Patrick Warren; Jean Giver; Michael R Go; Bryce A Kerlin
Journal:  J Pediatr       Date:  2018-12-07       Impact factor: 4.406

10.  Secondary Anticoagulation Prophylaxis for Catheter-Related Thrombosis in Pediatric Intestinal Failure: Comparison of Short- Vs Long-Term Treatment Protocols.

Authors:  Melanie Lissa Schmidt; Danielle Wendel; Simon Peter Horslen; Erin Richardson Lane; Leonardo Rodrigues Brandão; Emily Gottschalk; Christina Belza; Glenda Courtney-Martin; Paul William Wales; Yaron Avitzur
Journal:  JPEN J Parenter Enteral Nutr       Date:  2020-12-06       Impact factor: 4.016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.